Anthony Doyle Biocryst Pharmaceuticals Inc (BCRX) insider trading activity
Anthony Doyle is Chief Financial Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 377,867 shares of BCRX, which is worth approximately $2.9 Million. The most recent transaction as insider was on Dec 19, 2024, when has been sold 2,461 shares (Common Stock) at a price of $7.39 per share, resulting in proceeds of $18,186. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
378K
41.66%
3M change
66.14%
12M change
Total Value Held
$2.9 Million
Anthony Doyle Transaction History
AD
Anthony Doyle
Chief Financial Officer
Durham, NC